Health

N.C. Policy Collaboratory distributes $29 million for COVID-19 research

Funding 85 projects across 14 UNC System schools

Funding 85 projects across 14 UNC System schools

The N.C. Policy Collaboratory based at Carolina will distribute $29 million toward 85 research projects focused on treatment, community testing and prevention of COVID-19. These research projects are intended to provide new data and information to North Carolina lawmakers and policymakers to help guide the state’s pandemic response. The Collaboratory will be required to provide an update to the North Carolina General Assembly in September about the status of its research projects, which will be occurring across 14 UNC System campuses.

“Each one of these 85 projects will have a direct impact on improving the health and safety of North Carolinians,” said Chancellor Kevin M. Guskiewicz. “We are grateful for the opportunity to continue serving our state as we face this pandemic. We are looking forward to working with our fellow System schools to find solutions and strategies for fighting COVID-19.”

Read the complete Carolina Story…Opens in new window

Innovate and Impact Funding Priorities

Readers Also Viewed...

Sciences

Department of Energy funds milestone for North Carolina

Advancing solar energy research

Research

Grant goes to suicide prevention treatment

Using “mixed reality” in treating teens with suicidal thoughts and behaviors

UNC - Chapel Hill

Harvey Award goes to autism employer support, mobile app for well-water testing

Funding the two projects with $75,000 each, the award recognizes exemplary faculty who reflect the University’s commitment to innovative engagement and outreach that addresses real-world challenges. 

Community

Preparing for environmental threats

Developing strategies to strengthen community resilience

Alumni

The Homebound Project: Helping Hungry Kids

Raising money to help feed children affected by COVID-19

Research

Accelerating COVID-19 Research

A new fund will provide immediate support to Carolina’s COVID-19 research teams.